A decision chart for assessing and improving the transferability of economic evaluation results between countries

PharmacoEconomics
Robert WelteReiner Leidl

Abstract

To develop a user-friendly tool for managing the transfer of economic evaluation results. Factors that may influence the transfer of health economic study results were systematically identified and the way they impact on transferability was investigated. A transferability decision chart was developed that includes: knock-out criteria; a checklist based on the transferability factors; and methods for improving transferability and for assessing the uncertainty of transferred results. This approach was tested on various international cost-effectiveness studies in the areas of interventional cardiology, vaccination and screening. The transfer of study results is possible pending the outcomes of the transferability check and necessary adjustments. Transferability factors can be grouped into areas of methodological, healthcare system and population characteristics. Different levels of effort are required for analysis of factors, ranging from very low (e.g. discount rate) to very high (e.g. practice variation). The impact of differences of most transferability factors can be estimated via the key health economic determinants: capacity utilisation, effectiveness, productivity loss and returns to scale. Depending on the outcomes of the ...Continue Reading

References

Jan 1, 1991·International Journal of Technology Assessment in Health Care·M F Drummond, L Davies
Jan 1, 1993·Epidemiologic Reviews·P E Fine
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B M van IneveldP J van der Maas
Jun 13, 2000·Medizinische Klinik·J Köbberling
Jul 17, 2003·International Journal of Technology Assessment in Health Care·Taghreed AdamDavid B Evans
Apr 13, 2004·American Heart Journal·Lawrence LiaoKevin A Schulman

❮ Previous
Next ❯

Citations

Mar 3, 2010·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J C DavisC A Marra
Jun 22, 2007·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·J- Matthias Graf von der SchulenburgWolfgang Greiner
Sep 30, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Christina M Wenig
Dec 29, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Bernhard UltschOle Wichmann
Jul 21, 2011·Prevention Science : the Official Journal of the Society for Prevention Research·Silke B Wolfenstetter
May 9, 2012·International Journal of Technology Assessment in Health Care·Andres Pichon-RiviereMichael Drummond
Jul 26, 2005·Sexually Transmitted Diseases·Robert WelteMirjam Kretzschmar
Feb 25, 2010·Current Opinion in Clinical Nutrition and Metabolic Care·Jürgen JohnSilke B Wolfenstetter
Jan 22, 2008·Community Genetics·Poupak JavaherJorg Schmidtke
Oct 7, 2011·Cost Effectiveness and Resource Allocation : C/E·Talitha L FeenstraCaroline A Baan
Oct 8, 2011·Cost Effectiveness and Resource Allocation : C/E·Ernst-Günther HagenmeyerPeter K Schädlich
Jan 1, 2011·Health Economics Review·Silke B Wolfenstetter, Christina M Wenig
Aug 27, 2004·PharmacoEconomics·Fernando Antoñanzas
Sep 28, 2006·PharmacoEconomics·Jonas SchreyöggReinhard Busse
Mar 6, 2007·PharmacoEconomics·Pearl D GumbsOlaf H Klungel
Mar 6, 2007·PharmacoEconomics·Danielle E M BrunenbergManuela A Joore
Jul 6, 2007·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Peter K SchädlichJosef Georg Brecht
Nov 6, 2009·PharmacoEconomics·Federico AugustovskiSebastián García Martí
Jul 10, 2010·International Journal of Environmental Research and Public Health·Silke B Wolfenstetter, Christina M Wenig
Oct 16, 2010·International Journal of Environmental Research and Public Health·Sanjib SahaPia Johansson
Aug 31, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·O Wichmann, B Ultsch
Feb 25, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·W Ken Redekop
Jul 11, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Manuel HensManuel Posada de la Paz
Apr 12, 2014·BMC Health Services Research·Florian KoerberWolf Rogowski
Oct 27, 2005·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Stephanie BoulengerGerard de Pouvourville
Jul 12, 2008·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·John NixonGerard de Pouvourville
Aug 27, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Maria-Florencia HutterFernando Antonanzas
Jan 15, 2016·Health Economics·Zoltán KalóFinn Boerlum Kristensen
Dec 22, 2012·Journal of Medical Economics·George PapadopoulosManishi Prasad
Nov 5, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Florian Kirsch
May 3, 2008·Expert Review of Medical Devices·Lotte SteutenMartin Buxton
May 20, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Valentina LorenzoniGiuseppe Turchetti
Jul 23, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Christian Becker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Michael DrummondJohan L Severens
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
Stephanie BoulengerGerard de Pouvourville
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Saskia KniesJohan L Severens
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Marco BarbieriAdrian Towse
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Milton C WeinsteinISPOR Task Force on Good Research Practices--Modeling Studies
© 2021 Meta ULC. All rights reserved